BAX and cancer: The differential sensitivity of wt and Bax/Bak deficient cells is not due to altered FECH expression as WB analysis reveals similar expression of FECH in both cell sublines (Fig. 6, right) demonstrating that sensitivity of cancer cells for cell death induction by Alectinib/light treatment essentially depends on the activity of various cell death signaling pathways.